UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Medication persistence to antihypertensive drug treatment - a cross-sectional study of attitudes towards hypertension and medication in persistent and non-persistent patients

Blood pressure, 2019-09, Vol.28 (5), p.309-316

2019

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of treatment-resistant hypertension and important associated factors—results from the Swedish Primary Care Cardiovascular Database

Journal of the American Society of Hypertension, 2016-11, Vol.10 (11), p.838-846

2016

Link zum Volltext

Verfügbarkeit prüfen

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial

Journal of hypertension, 2002-10, Vol.20 (10), p.2089-2093

2002

Link zum Volltext

Verfügbarkeit prüfen

Heart Failure Events in a Clinical Trial on Arterial Hypertension: New Insights Into the SPRINT Trial

Hypertension (Dallas, Tex. 1979), 2021-11, Vol.78 (5), p.1241-1247

2021

Link zum Volltext

Verfügbarkeit prüfen

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

European heart journal, 2013-07, Vol.34 (28), p.2159-2219

2013

Link zum Volltext

Verfügbarkeit prüfen

Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity

The journal of clinical hypertension (Greenwich, Conn.), 2018-01, Vol.20 (1), p.106-114

2018

Link zum Volltext

Verfügbarkeit prüfen

Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation

Journal of hypertension, 2018-01, Vol.36 (1), p.151-158

2018

Link zum Volltext

Verfügbarkeit prüfen

Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD)

Medicine (Baltimore), 2016-10, Vol.95 (40), p.e4908-e4908

2016

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular outcome in treatment-resistant hypertension: results from the Swedish Primary Care Cardiovascular Database (SPCCD)

Journal of hypertension, 2018-02, Vol.36 (2), p.402-409

2018

Link zum Volltext

Verfügbarkeit prüfen

Persistence to antihypertensive drug treatment in Swedish primary healthcare

European journal of clinical pharmacology, 2013-11, Vol.69 (11), p.1955-1964

2013

Link zum Volltext

Verfügbarkeit prüfen

Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD)

European journal of preventive cardiology, 2017-07, Vol.24 (11), p.1206-1211

2017

Link zum Volltext

Verfügbarkeit prüfen

Markers of Inflammation, Endothelial Activation, and Arterial Stiffness in Hypertensive Heart Disease and the Effects of Treatment: Results From the SILVHIA Study

Journal of cardiovascular pharmacology, 2013-12, Vol.62 (6), p.559-566

2013

Link zum Volltext

Verfügbarkeit prüfen

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

Journal of hypertension, 2007-09, Vol.25 (9), p.1958-1966

2007

Link zum Volltext

Verfügbarkeit prüfen

The Swedish Primary Care Cardiovascular Database (SPCCD): 74 751 hypertensive primary care patients

Blood pressure, 2014-04, Vol.23 (2), p.116-125

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity

Journal of hypertension, 2007, Vol.25 (1), p.169-175

2007

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular risk factors are not treated to target in hypertensive patients in primary care

Blood pressure, 2010, Vol.19 (3), p.176-181, Article 176

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)

The American journal of cardiology, 2002-11, Vol.90 (10), p.1107-1112

2002

Link zum Volltext

Verfügbarkeit prüfen

The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial

International journal of clinical practice (Esher), 2010-08, Vol.64 (9), p.1228-1234

2010

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

Journal of hypertension, 2002, Vol.20 (4), p.657-663

2002

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Antihypertensive Treatment on the Doppler-Derived Myocardial Performance Index in Patients with Hypertensive Left Ventricular Hypertrophy: Results from the Swedish Irbesartan in Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)

Echocardiography (Mount Kisco, N.Y.), 2009-08, Vol.26 (7), p.753-758

2009

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin II type 1 (AT 1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide

American journal of hypertension, 2000-05, Vol.13 (5), p.504-511

2000

Link zum Volltext

Verfügbarkeit prüfen

Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA)

American journal of hypertension, 2006-09, Vol.19 (9), p.927-936

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaAged

ThemaAntihypertensive Agents - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Female
(22)
Humans
(22)
Medicin Och Hälsovetenskap
(22)
Middle Aged
(22)
Male
(21)
Hypertension - Drug Therapy
(20)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Cardiovascular System & Cardiology
(16)
Hypertension
(15)
Adult
(12)
Peripheral Vascular Disease
(12)
Blood Pressure
(11)
Hypertension - Physiopathology
(11)
Biological And Medical Sciences
(8)
Biphenyl Compounds - Therapeutic Use
(8)
Kardiologi
(8)
Medical Sciences
(8)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Medication persistence to antihypertensive drug treatment - a cross-sectional study of attitudes towards hypertension and medication in persistent and non-persistent patients

Prevalence of treatment-resistant hypertension and important associated factors—results from the Swedish Primary Care Cardiovascular Database

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial

Heart Failure Events in a Clinical Trial on Arterial Hypertension: New Insights Into the SPRINT Trial

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity

Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation

Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD)

Cardiovascular outcome in treatment-resistant hypertension: results from the Swedish Primary Care Cardiovascular Database (SPCCD)

Persistence to antihypertensive drug treatment in Swedish primary healthcare

Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD)

Markers of Inflammation, Endothelial Activation, and Arterial Stiffness in Hypertensive Heart Disease and the Effects of Treatment: Results From the SILVHIA Study

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

The Swedish Primary Care Cardiovascular Database (SPCCD): 74 751 hypertensive primary care patients

Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity

Cardiovascular risk factors are not treated to target in hypertensive patients in primary care

Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)

The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

The Effects of Antihypertensive Treatment on the Doppler-Derived Myocardial Performance Index in Patients with Hypertensive Left Ventricular Hypertrophy: Results from the Swedish Irbesartan in Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)

Angiotensin II type 1 (AT 1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide

Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA)

Aktive Filter

Suchergebnisse filtern